Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole Augmentation in MDD
NCT00683852Phase 3Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Sep 2008
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aripiprazole in major depressive disorder (MDD), sponsored by Massachusetts General Hospital. Started Sep 2008; status: completed.
02
Drugs
aripiprazole
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00683852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00683852.